Cardiogenic shock triggered by verapamil and atenolol: a case report of therapeutic experience with intravenous calcium.
Cardiogenic shock developed in a 72-year-old Japanese woman during combination therapy with verapamil and atenolol for recurrent supraventricular arrhythmia. She had coronary atherosclerosis, liver cirrhosis and bradycardia-tachycardia syndrome. Despite of the high-dose catecholamines and counterpulsation, she progressively deteriorated. Bolus administration of intravenous calcium chloride (CaCl2) immediately resolved her hemodynamic collapse.
Sakurai
H
H
Department of Cardiology, Toki General Hospital, Toki City, Gifu, Japan.
Kei
M
M
Matsubara
K
K
Yokouchi
K
K
Hattori
K
K
Ichihashi
R
R
Hirakawa
Y
Y
Tsukamoto
H
H
Saburi
Y
Y
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D000368:Aged; D001262:Atenolol / Q000008:administration & dosage / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology; D001919:Bradycardia / Q000150:complications / Q000628:therapy; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000009:adverse effects*; D020746:Calcium Channels, L-Type / Q000187:drug effects / Q000502:physiology; D002122:Calcium Chloride / Q000008:administration & dosage / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D015908:Counterpulsation; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000178:diet therapy; D017379:Hypertrophy, Left Ventricular / Q000150:complications; D007275:Injections, Intravenous; D008103:Liver Cirrhosis / Q000150:complications; D010138:Pacemaker, Artificial; D012770:Shock, Cardiogenic / Q000139:chemically induced* / Q000188:drug therapy / Q000628:therapy; D013617:Tachycardia, Supraventricular / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects*; D014700:Verapamil / Q000008:administration & dosage / Q000009:adverse effects*
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D020746:Calcium Channels, L-Type; D014665:Vasodilator Agents; D001262:Atenolol; D014700:Verapamil; D002122:Calcium Chloride